Vir Biotechnology Inc (NAS:VIR)
$ 9.5 +0.090 (+0.96%) Market Cap: 1.61 Bil Enterprise Value: 1.17 Bil PE Ratio: 0 PB Ratio: 1.63 GF Score: 52/100

Q1 2026 Vir Biotechnology Inc Earnings Call Transcript

May 6, 2026 / 08:30 PM GMT
Release Date Price: $10.29 (+2.80%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

VIR.OQ - Vir Biotechnology Inc
Q1 2026 Vir Biotechnology Inc Earnings Call
May 06, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello, and welcome to Veer Biotechnologies First Quarter 2026 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. I will now turn the call over to Kiki Patel, Head of Investor Relations. You may begin, Kiki.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and welcome, everyone. Earlier today, we issued a press release reporting our first quarter 2026 financial results and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot